69 related articles for article (PubMed ID: 9346827)
1. 1H NMR structural study of free and template-linked antigenic peptide representing the C-terminal region of the heavy chain of influenza virus hemagglutinin.
Wilce JA; Zeng W; Rose K; Craik DJ; Jackson DC
Biomed Pept Proteins Nucleic Acids; 1996; 2(2):51-8. PubMed ID: 9346827
[TBL] [Abstract][Full Text] [Related]
2. Branched polypeptides as antigens for influenza virus hemagglutinin and T-cell receptor subunits.
Tóth GK; Váradi G; Nagy Z; Monostori E; Penke B; Hegedüs Z; Andó I; Fazekas G; Kurucz I; Mák M
Pept Res; 1993; 6(5):272-80. PubMed ID: 8257803
[TBL] [Abstract][Full Text] [Related]
3. Conformation study of HA(306-318) antigenic peptide of the haemagglutinin influenza virus protein.
Bertrand A; Brito RM; Alix AJ; Lancelin JM; Carvalho RA; Geraldes CF; Lakhdar-Ghazal F
Spectrochim Acta A Mol Biomol Spectrosc; 2006 Nov; 65(3-4):711-8. PubMed ID: 16497544
[TBL] [Abstract][Full Text] [Related]
4. Membrane binding of pH-sensitive influenza fusion peptides. positioning, configuration, and induced leakage in a lipid vesicle model.
Esbjörner EK; Oglecka K; Lincoln P; Gräslund A; Nordén B
Biochemistry; 2007 Nov; 46(47):13490-504. PubMed ID: 17973492
[TBL] [Abstract][Full Text] [Related]
5. Universal influenza B vaccine based on the maturational cleavage site of the hemagglutinin precursor.
Bianchi E; Liang X; Ingallinella P; Finotto M; Chastain MA; Fan J; Fu TM; Song HC; Horton MS; Freed DC; Manger W; Wen E; Shi L; Ionescu R; Price C; Wenger M; Emini EA; Cortese R; Ciliberto G; Shiver JW; Pessi A
J Virol; 2005 Jun; 79(12):7380-8. PubMed ID: 15919893
[TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen.
Jackson DC; Brown LE
Pept Res; 1991; 4(3):114-24. PubMed ID: 1823182
[TBL] [Abstract][Full Text] [Related]
7. A polar octapeptide fused to the N-terminal fusion peptide solubilizes the influenza virus HA2 subunit ectodomain.
Chen J; Skehel JJ; Wiley DC
Biochemistry; 1998 Sep; 37(39):13643-9. PubMed ID: 9753451
[TBL] [Abstract][Full Text] [Related]
8. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
Nakajima S; Nobusawa E; Nakajima K
Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
10. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
11. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion.
Epand RF; Macosko JC; Russell CJ; Shin YK; Epand RM
J Mol Biol; 1999 Feb; 286(2):489-503. PubMed ID: 9973566
[TBL] [Abstract][Full Text] [Related]
12. Full-length influenza hemagglutinin HA2 refolds into the trimeric low-pH-induced conformation.
Swalley SE; Baker BM; Calder LJ; Harrison SC; Skehel JJ; Wiley DC
Biochemistry; 2004 May; 43(19):5902-11. PubMed ID: 15134464
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization and topology of the second potential membrane anchor region in the thromboxane A2 synthase amino-terminal domain.
Ruan KH; Li D; Ji J; Lin YZ; Gao X
Biochemistry; 1998 Jan; 37(3):822-30. PubMed ID: 9454571
[TBL] [Abstract][Full Text] [Related]
14. Conformation and interaction with the membrane models of the amino-terminal peptide of influenza virus hemagglutinin HA2 at fusion pH.
Chang DK; Cheng SF; Trivedi VD
Arch Biochem Biophys; 2001 Dec; 396(1):89-98. PubMed ID: 11716466
[TBL] [Abstract][Full Text] [Related]
15. Identification of amino acid residues of influenza A virus H3 HA contributing to the recognition of molecular species of sialic acid.
Takahashi T; Hashimoto A; Maruyama M; Ishida H; Kiso M; Kawaoka Y; Suzuki Y; Suzuki T
FEBS Lett; 2009 Oct; 583(19):3171-4. PubMed ID: 19720062
[TBL] [Abstract][Full Text] [Related]
16. Peptide affinity and concentration affect the sensitivity of M3-restricted CTLs induced in vitro.
Byers DE; Lindahl KF
J Immunol; 1999 Sep; 163(6):3022-8. PubMed ID: 10477565
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.
Casares S; Stan AC; Bona CA; Brumeanu TD
Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728
[TBL] [Abstract][Full Text] [Related]
18. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
[TBL] [Abstract][Full Text] [Related]
19. Antigenic and immunogenic properties of synthetic peptide-based T-cell determinant polymers.
Jackson DC; Fitzmaurice C; Sheppard RC; McMurray J; Brown LE
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):171-6. PubMed ID: 9346849
[TBL] [Abstract][Full Text] [Related]
20. Free energy simulations reveal a double mutant avian H5N1 virus hemagglutinin with altered receptor binding specificity.
Das P; Li J; Royyuru AK; Zhou R
J Comput Chem; 2009 Aug; 30(11):1654-63. PubMed ID: 19399777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
